The results from Moderna’s early-stage trial, which include data from 20 participants, are important because older adults often don’t respond as well to vaccines as younger adults.
Worried about being left behind when a Covid vaccine is ready, dozens of labs, researchers and companies from Thailand to Nigeria are bootstrapping their own work on inoculations.
India, however, is in a good position because many companies are working on vaccine development, either on their own or in collaboration, chief scientist Soumya Swaminathan added.
Ensuring worldwide supply, collaborating on vaccines, pricing for access, risk sharing & fixing a broken market are some of the pressing needs that the drugmakers should focus on
Russian Ambassador to India Nikolay Kudashev has contacted offices of principal scientific advisor & secretaries of dept of health research, and biotechnology in this regard.
Until now, most tests could tell only whether antibodies are present. The newer ones measure the quantity of proteins raised by the immune system to disable viral invaders.
Dept of Pharmaceuticals secretary has asked pharma companies to review implementation of marketing ethics to ensure hoarding & leakages in drug distribution are stopped.
RBI Handbook of Statistics shows state’s GSDP has more than doubled in past decade, finishing second behind Maharashtra. It has performed well across health & education parameters as well.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS